256 related articles for article (PubMed ID: 1931705)
1. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
Boussiotis VA; Pangalis GA
Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
McSweeney EN; Giles FJ; Worman CP; Jewel AP; Tsakona CP; Hoffbrand AV; Mehta AB; Newland AC; Cawley JC; Galvani D
Br J Haematol; 1993 Sep; 85(1):77-83. PubMed ID: 8251412
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial with alpha 2b-interferon in 26 stage A untreated B-chronic lymphocytic leukemia patients.
Boussiotis VA; Pangalis GA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):471-3. PubMed ID: 3065744
[TBL] [Abstract][Full Text] [Related]
4. Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report.
Pangalis GA; Griva E
Cancer; 1988 Mar; 61(5):869-72. PubMed ID: 3338053
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
Silver RT; Peterson BL; Szatrowski TP; Powell BL; Stock W; Carroll AJ; Bloomfield CD; Schiffer CA; Larson RA
Leuk Lymphoma; 2003 Jan; 44(1):39-48. PubMed ID: 12691141
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.
Langenmayer I; Nerl C; Knauf W; Dempster S; Hallek M; Adorf D; Dietzfelbinger H; Busch R; Ziegler-Heitbrock HW; Thiel E; Emmerich B
Br J Haematol; 1996 Aug; 94(2):362-9. PubMed ID: 8759897
[TBL] [Abstract][Full Text] [Related]
7. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
[TBL] [Abstract][Full Text] [Related]
8. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
[TBL] [Abstract][Full Text] [Related]
9. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
[TBL] [Abstract][Full Text] [Related]
10. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
Manns MP; McHutchison JG; Gordon SC; Rustgi VK; Shiffman M; Reindollar R; Goodman ZD; Koury K; Ling M; Albrecht JK
Lancet; 2001 Sep; 358(9286):958-65. PubMed ID: 11583749
[TBL] [Abstract][Full Text] [Related]
12. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
[TBL] [Abstract][Full Text] [Related]
13. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H;
Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809
[TBL] [Abstract][Full Text] [Related]
14. Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia.
Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Dianzani F
Eur J Cancer; 1991; 27 Suppl 4():S14-7. PubMed ID: 1799466
[TBL] [Abstract][Full Text] [Related]
15. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
Demeter J; Paloczi K; Bibok G; Lehoczky D
Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
[TBL] [Abstract][Full Text] [Related]
16. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy.
Ferrara F; Rametta V; Mele G; Antinolfi I; Mettivier V; Cimino R
Am J Hematol; 1992 Sep; 41(1):45-9. PubMed ID: 1503098
[TBL] [Abstract][Full Text] [Related]
18. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.
Scotto G; Fazio V; Palumbo E; Cibelli DC; Saracino A; Angarano G
New Microbiol; 2005 Jan; 28(1):23-9. PubMed ID: 15782623
[TBL] [Abstract][Full Text] [Related]
19. alpha Interferon in chronic lymphocytic leukaemia.
Montserrat E; Villamor N; Urbano-Ispizua A; Ribera JM; Rozman C
Eur J Cancer; 1991; 27 Suppl 4():S74-7. PubMed ID: 1839211
[TBL] [Abstract][Full Text] [Related]
20. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]